Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort studyMichela Botta, Liselotte Hol, Jasper J. Haringman et al.|The Lancet Respiratory Medicine|2020Cited by 306
Association of intensity of ventilation with 28-day mortality in COVID-19 patients with acute respiratory failure: insights from the PRoVENT-COVID studyM.T.U. Schuijt, Eline S. de Klerk, Jasper J. Haringman et al.|Critical Care|2021Cited by 40
RELAx – REstricted versus Liberal positive end-expiratory pressure in patients without ARDS: protocol for a randomized controlled trialFrederique Paulus, Hazra S. Moeniralam, Henrik Endeman et al.|Trials|2018Cited by 22
Prognostication using SpO2/FiO2 in invasively ventilated ICU patients with ARDS due to COVID-19 – Insights from the PRoVENT-COVID studyJan-Paul Roozeman, D.I. van den Bersselaar, C.K. Algoe et al.|Journal of Critical Care|2021Cited by 22
Association between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients — insights from the PRoVENT-COVID study: a national, multicenter, observational cohort analysisSanchit Ahuja, Janneke Horn, Jasper J. Haringman et al.|Critical Care|2022Cited by 21